What is the scope of this report?

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry. Read More

Which segments covered in this report?

Market is segmented by Types, Applications, Technology, End-use Industries, and Regions. Read More

What are the key factors covered in this report?

The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions. Read More

Thymosin Α1 Market

Q: Does this report offer customization?

Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs. Read More

Report Code : 286281
Industry : Healthcare and Pharmaceuticals
Published On : Aug 2019
Pages : 98
Publisher : Verified Market Intelligence
Format:

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Request Sample

What is Thymosin α1?
Thymosin α1 is a protein in humans encoded by the PTMA gene, which is a peptide fragment derived from prothymosin alpha, exhibits a variety of immunoregulating properties. It is approved for the treatment of Hepatitis B and C, in 35 under-developed or developing countries.

Global Thymosin α1 Market Outlook
The rising burden and incidence of HAV and HBV are driving the growth of Thymosin α1 market. In 2015, 257 million people were diagnosed with chronic HBV infection, and 71 million people with chronic HCV infection, this figure to reach a peak by 2030. Eastern Mediterranean Region and the European Region are reported with the highest prevalence of HCV.
Ongoing trials and research for new applications or treatments to propel the growth of the market. Clinical trials entail that thymosin α1 can be useful in cystic fibrosis, peritonitis, acute cytomegalovirus infection, TB, severe acute respiratory syndrome, and lung infections in critically ill patients., septic shock and acute respiratory distress syndrome. It has been studied for probable use in treating cancer during chemotherapy. Thymosin α1 has been given to subjects with lung, gastric, or breast cancer in China. It was given for evaluation during one of two cycles of chemotherapy and QOL, treatment with Thymosin α1 provided a significant improvement in all measures of QOL as well as a lowered occurrence of infections during chemotherapy and increased immune parameters. Lack of awareness among the rural population about hepatitis and its treatment is hindering the growth of the market.

Global Thymosin α1 Market Competitive Landscape
The "Global Thymosin α1 Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such as Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical, Hainan Zhonghe Pharmaceutical, SciClone Pharmaceuticals, Abbiotec, Shanghai Soho-Yiming Pharmaceuticals, Hybio Pharmaceutical and Hainan Shuangcheng Pharmaceuticals. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis.

Customization of the Report
• In case of any queries or customization requirements please connect with our sales team, who will ensure that your requirements are met.

1. INTRODUCTION OF GLOBAL THYMOSIN Α1 MARKET

1.1. Overview of the Market

1.2. Scope of Report

1.3. Assumptions


2. EXECUTIVE SUMMARY


3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1. Data Mining

3.2. Validation

3.3. Primary Interviews

3.4. List of Data Sources


4. GLOBAL THYMOSIN Α1 MARKET OUTLOOK

4.1. Overview

4.2. Market Dynamics

4.2.1. Drivers

4.2.2. Restraints

4.2.3. Opportunities

4.3. Porters Five Force Model

4.4. Value Chain Analysis

5. GLOBAL THYMOSIN Α1 MARKET, BY TYPE

5.1. Overview

5.2. Freeze-dried Powder

5.3. Injection


6. GLOBAL THYMOSIN Α1 MARKET, BY DISTRIBUTION CHANNEL

6.1. Overview

6.2. Hospital Pharmacies

6.3. Retail Pharmacies

6.4. Online Pharmacies


7. GLOBAL THYMOSIN Α1 MARKET, BY GEOGRAPHY

7.1. Overview

7.2. North America 

7.2.1. U.S.

7.2.2. Canada

7.2.3. Mexico

7.3. Europe

7.3.1. Germany

7.3.2. U.K.

7.3.3. France

7.3.4. Rest of Europe

7.4. Asia Pacific

7.4.1. China

7.4.2. Japan

7.4.3. India

7.4.4. Rest of Asia Pacific

7.5. Rest of the World

7.5.1. Latin America 

7.5.2. Middle East & Africa 


8. GLOBAL THYMOSIN Α1 MARKET COMPETITIVE LANDSCAPE

8.1. Overview

8.2. Company Market Ranking 

8.3. Key Development Strategies

9. COMPANY PROFILES

9.1. Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical

10.1.1 Overview

10.1.2 Financial Performance

10.1.3 Product Outlook

10.1.4 Key Developments

9.2. Abbiotec

9.2.1. Overview

9.2.2. Financial Performance

9.2.3. Product Outlook

9.2.4. Key Developments

9.3. Shanghai Soho-Yiming Pharmaceuticals

9.3.1. Overview

9.3.2. Financial Performance

9.3.3. Product Outlook

9.3.4. Key Developments

9.4. Hybio Pharmaceutical

9.4.1. Overview

9.4.2. Financial Performance

9.4.3. Product Outlook

9.4.4. Key Developments

9.5. Hainan Shuangcheng Pharmaceuticals

9.5.1. Overview

9.5.2. Financial Performance

9.5.3. Product Outlook

9.5.4. Key Developments

10. Appendix

10.1. Related Reports

2023-2028 Global and Regional Thymosin Industry Status and Prospects Professional Market Research Report Standard Version

Price : US$ 3,500	Date : Sep 2023
Category : Healthcare and Pharmaceuticals	Pages : 155

2023-2028 Global and Regional Thymosin Immune Modulators Industry Status and Prospects Professional Market Research Report Standard Version

Price : US$ 3,500	Date : Sep 2023
Category : Healthcare and Pharmaceuticals	Pages : 147

Global Thymosin A1 Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030

Price : US$ 3,500	Date : Jul 2023
Category : Healthcare and Pharmaceuticals	Pages : 231

2022-2027 Global and Regional Thymosin α1 Industry Status and Prospects Professional Market Research Report Standard Version

Price : US$ 3,500	Date : Oct 2022
Category : Healthcare and Pharmaceuticals	Pages : 157

2022-2027 Global and Regional Thymosin Industry Status and Prospects Professional Market Research Report Standard Version

Price : US$ 3,500	Date : Sep 2022
Category : Healthcare and Pharmaceuticals	Pages : 161

Choose License Type

Happy To Assist You

We will be happy to help you find what you need. Please call us or write to us:

Email
sales@worldwidemarketreports.com
United States Of America

+1-415-871-0703
United Kingdom

+44-203-289-4040
Australia

+61-2-4786-0457
INDIA

+91-848-285-0837

Frequently Asked Questions

What does this report covers?

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.

Does this report estimates the current market size?

The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.

Does the report provides Market Size in terms of – Value (US$ Mn) and Volume (Thousands Units)?

The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).

What are the key segments offered in this report?

Market is segmented by:

Which market dynamics covered in this report?

The report share key insights on the following:

It helps the businesses in making investments decisions.

Does this report offer customization?

Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.